1. Home
  2. BLTE vs GTES Comparison

BLTE vs GTES Comparison

Compare BLTE & GTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$137.18

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Logo Gates Industrial Corporation plc

GTES

Gates Industrial Corporation plc

HOLD

Current Price

$24.55

Market Cap

6.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLTE
GTES
Founded
2018
1911
Country
United States
United States
Employees
N/A
13000
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.2B
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
BLTE
GTES
Price
$137.18
$24.55
Analyst Decision
Strong Buy
Buy
Analyst Count
7
9
Target Price
$198.00
$28.56
AVG Volume (30 Days)
104.2K
2.0M
Earning Date
05-08-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.73
EPS
N/A
0.23
Revenue
N/A
N/A
Revenue This Year
N/A
$5.83
Revenue Next Year
$492.11
$3.95
P/E Ratio
N/A
$106.65
Revenue Growth
N/A
N/A
52 Week Low
$56.68
$20.59
52 Week High
$200.00
$28.47

Technical Indicators

Market Signals
Indicator
BLTE
GTES
Relative Strength Index (RSI) 31.51 47.74
Support Level $103.94 $23.84
Resistance Level $172.02 $26.29
Average True Range (ATR) 7.11 0.79
MACD -1.16 -0.19
Stochastic Oscillator 7.06 40.00

Price Performance

Historical Comparison
BLTE
GTES

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About GTES Gates Industrial Corporation plc

Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.

Share on Social Networks: